Skip to content
About
Science
Pipeline
Investors & Media
FAQs
Contact
Investors & Media
All
Articles
Press Releases
Publications & Presentations
All
Articles
Press Releases
Publications & Presentations
Press Releases
Immusoft To Present on ISP-001 Clinical Trial at WORLDSymposium™ 2024 Conference
January 3, 2024
Business Wire
Press Releases
Immusoft Administers the First Engineered B Cell in a Human Clinical Trial
December 15, 2023
Immusoft
Press Releases
Immusoft Acquires Exclusive, Worldwide Rights to Intellectual Property for Genome Edited Primary B Cells from the University of Minnesota
March 27, 2023
Immusoft
Press Releases
Immusoft Awarded $8M in Funding from the California Institute for Regenerative Medicine (CIRM) for MPS I Clinical Program
January 27, 2023
Immusoft
Press Releases
Immusoft Announces FDA Clearance of IND Application for ISP-001 for MPS I, the First Engineered B Cell Therapy to Enter into Clinical Trials
September 1, 2022
Immusoft
Press Releases
Immusoft to Present at WORLDSymposium™ 2022 Conference
February 7, 2022
Immusoft
Press Releases
Immusoft Receives $4M in Funding from the California Institute for Regenerative Medicine (CIRM)
November 29, 2021
Immusoft
Press Releases
Immusoft and Takeda Collaborate to Discover and Develop Cell Therapies for Rare Neurometabolic Disorders
October 13, 2021
Immusoft
Press Releases
Immusoft Announces Formation of Scientific Advisory Board
June 23, 2021
Immusoft
Press Releases
Immusoft to Present at ASGCT 23rd Annual Meeting
May 12, 2020
Immusoft
Previous Page
1
2
3
More News
